PMID: 2495499Feb 1, 1989Paper

Cost effectiveness of current approaches to the control of retinopathy in type I diabetics

Ophthalmology
J C JavittA Sommer

Abstract

Diabetic retinopathy is a leading cause of blindness among working age Americans. The epidemiology of diabetic eye disease has been well described in population-based studies and the effects of laser treatment have been tested in randomized controlled trials. The authors have designed a computer simulation model using the published reports of these studies to predict the medical and economic effects of applying currently accepted methods for the control of diabetic retinopathy to the population of type I diabetics. Recommendations for screening are taken from the Public Health Committee of the American Academy of Ophthalmology. Treatment recommendations and treatment efficacy are drawn from the reports of the Diabetic Retinopathy Study (DRS) and the Early Treatment Diabetic Retinopathy Study (ETDRS). Costs of screening and treatment are drawn from published Medicare reimbursement data. Over a 60-year period, the model predicts that proliferative diabetic retinopathy (PDR) requiring panretinal photocoagulation (PRP) will eventually develop in 72% of type I diabetics and macular edema will develop in 42%. If these treatments are delivered as recommended in the clinical trials, the model predicts a cost of $966 per person-year of ...Continue Reading

References

May 1, 1987·Diabetes Care·L R WulsinL I Rand
Jul 1, 1985·Diabetes Care·R KleinD L DeMets
Jan 1, 1983·Diabetes Care·L J MeltonC P Chu
Mar 1, 1965·American Journal of Public Health and the Nation's Health·H H MARKS

❮ Previous
Next ❯

Citations

Dec 1, 1992·Diabetes/metabolism Reviews·T J Songer
Nov 1, 1991·Diabetologia·E M Kohner, M Porta
Jan 1, 1994·International Ophthalmology·A Sommer
Sep 9, 2011·Journal of Digital Imaging·Siti Syafinah Ahmad HassanMallika Premsenthil
Aug 10, 2006·Japanese Journal of Ophthalmology·Apichart SingalavanijaViravud Kongbunkiat
May 1, 1992·Social Science & Medicine·M F DrummondF L Ferris
May 1, 1996·Journal of Diabetes and Its Complications·A McGuire
Apr 6, 2005·American Journal of Ophthalmology·Arnd GandorferAnselm Kampik
Feb 13, 2001·American Journal of Ophthalmology·H Lewis
Apr 11, 2003·Survey of Ophthalmology·Melissa M BrownJennifer Landy
Mar 1, 1997·Endocrinology and Metabolism Clinics of North America·T N Taylor, E A Chrischilles
Jan 1, 1992·International Journal of Technology Assessment in Health Care·A M FendrickY P Chiang
Jan 1, 1996·International Journal of Technology Assessment in Health Care·B S Bloom, A M Fendrick
Aug 8, 2001·The Australian Journal of Rural Health·S J LeeJ E Keeffe
Jul 18, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·N YounisJ P Vora
Aug 26, 1999·The New England Journal of Medicine·F L FerrisL M Aiello
Jul 26, 2012·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Paolo S SilvaLloyd Paul Aiello
Apr 13, 2004·Retina·Gary C BrownSanjay Sharma
Oct 16, 2008·Retina·Jordana K SchmierG Philip Matthews
Apr 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·M Porta, E Kohner
Aug 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·N Wareham, R Greenwood
Dec 20, 2005·The British Journal of Ophthalmology·E Stefánsson
Nov 1, 1996·The British Journal of Ophthalmology·G G GardnerA T Elliott
Jul 22, 1999·The British Journal of Ophthalmology·C SinthanayothinT H Williamson
Jun 16, 2000·BMJ : British Medical Journal·M JamesS P Harding
Jul 1, 1991·American Journal of Public Health·T W Kelsey, P L Jenkins
Jun 2, 2012·Clinical Ophthalmology·Yoshinobu MizunoChika Shigeyasu
Apr 1, 1997·American Journal of Ophthalmology·H R Taylor
Feb 27, 2007·Ophthalmology·David B ReinStephen W Sorensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.